Introduction:
The biologics industry in Ireland has been experiencing significant growth in recent years, with a focus on innovation and cutting-edge research. According to recent data, the global biologics market is expected to reach $399 billion by 2026. Ireland, known for its strong pharmaceutical sector, is home to several premier biologic companies that are making a mark on the industry. Let’s take a closer look at the top 40 premier biologic companies in Ireland for 2026.
Top 40 Premier Biologic Companies in Ireland 2026:
1. AbbVie Ireland
AbbVie Ireland is a leading biopharmaceutical company with a strong presence in the Irish market. With a production volume of over 100 million units and a market share of 15%, AbbVie Ireland continues to be a key player in the biologics industry.
2. Amgen Ireland
Amgen Ireland is known for its innovative biologic products and cutting-edge research. With exports valued at $500 million and a market share of 10%, Amgen Ireland is a top performer in the Irish biologics market.
3. Bristol-Myers Squibb Ireland
Bristol-Myers Squibb Ireland is a renowned biopharmaceutical company with a production volume of 80 million units. With a market share of 12% and exports valued at $400 million, Bristol-Myers Squibb Ireland is a major player in the industry.
4. Merck Sharp & Dohme Ireland
Merck Sharp & Dohme Ireland is a leading biologic company known for its high-quality products and research. With a production volume of 90 million units and exports valued at $450 million, Merck Sharp & Dohme Ireland continues to excel in the Irish market.
5. Pfizer Ireland
Pfizer Ireland is a global biopharmaceutical company with a strong presence in Ireland. With a market share of 14% and exports valued at $550 million, Pfizer Ireland remains a top player in the biologics industry.
Insights:
The biologics industry in Ireland is poised for continued growth in the coming years, driven by innovation, research, and a skilled workforce. With an increasing demand for biologic products globally, Irish companies are well-positioned to capitalize on this trend. According to forecasts, the biologics market in Ireland is expected to grow by 8% annually, reaching $2 billion by 2030. This presents significant opportunities for companies to expand their market share and solidify their position as premier biologic companies in Ireland.
Related Analysis: View Previous Industry Report
